Benitec Biopharma has developed a breakthrough platform for treating human diseases called ddRNAi.
Unlike other RNAi-based technologies, ddRNAi effects lasting change in target cells, leading to long term benefit and, potentially, cure.
All ASX Announcements
Benitec announces pricing of US IPO & NASDAQ Listing
See our technology explained
siRNA vs shRNA
How ddRNAi works